Interpace Biosciences (IDXG) Reports Q1 EPS of $0.03

Interpace Biosciences (OTC: IDXG) reported Q1 EPS of $0.03. Revenue for the quarter came in at $9.03 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Integra Resources (ITRG) Tops Q2 EPS by 6c
• Deutsche Bank Upgrades Entegris Inc (ENTG) to Buy